SELLAS Life Sciences Group (SLS) Income from Continuing Operations: 2011-2023
Historic Income from Continuing Operations for SELLAS Life Sciences Group (SLS) over the last 4 years, with Dec 2023 value amounting to -$8.2 million.
- SELLAS Life Sciences Group's Income from Continuing Operations rose 13.43% to -$8.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$37.9 million, marking a year-over-year increase of 9.73%. This contributed to the annual value of -$37.9 million for FY2023, which is 8.31% up from last year.
- SELLAS Life Sciences Group's Income from Continuing Operations amounted to -$8.2 million in Q4 2023, which was up 12.65% from -$9.4 million recorded in Q3 2023.
- In the past 5 years, SELLAS Life Sciences Group's Income from Continuing Operations registered a high of -$2.2 million during Q1 2021, and its lowest value of -$16.7 million during Q1 2022.
- In the last 3 years, SELLAS Life Sciences Group's Income from Continuing Operations had a median value of -$8.8 million in 2022 and averaged -$8.8 million.
- Per our database at Business Quant, SELLAS Life Sciences Group's Income from Continuing Operations soared by 44.76% in 2021 and then tumbled by 645.43% in 2022.
- Quarterly analysis of 4 years shows SELLAS Life Sciences Group's Income from Continuing Operations stood at -$4.2 million in 2020, then tumbled by 179.37% to -$11.6 million in 2021, then climbed by 18.70% to -$9.4 million in 2022, then increased by 13.43% to -$8.2 million in 2023.
- Its last three reported values are -$8.2 million in Q4 2023, -$9.4 million for Q3 2023, and -$9.1 million during Q2 2023.